[
  {
    "sentence": "With a conjFDR < 0.05, 4093 pleiotropic variants were identified, ranging from 3 to 1689, associated with gastroesophageal cancer and BC#1, respectively (Fig. 2b and Additional file 1: Table S15).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Next, mapping the variants to genetic elements using BioMart annotations [42] identified a range from 0 (gastroesophageal cancer) to 560 (BC#1) protein-coding genes, and relatively minor contributions from other elements (Fig. 2c).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "As expected, the larger cancer studies revealed more pleiotropic associations, with the exception of HER2-positive breast cancer, which yielded only 26 variants; in contrast, the melanoma and prostate studies showed comparatively more pleiotropic associations (385 and 356 variants, respectively) (Fig. 2b,d and Additional file 1: Table S15).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From the perspective of blood traits, mean corpuscular volume (MCV) and platelet count (PLT#) showed the greatest number of shared genetic variants and pleiotropic gene candidates (i.e., genes mapped to pleiotropic variants), respectively, while nucleated red blood cells showed the weakest evidence of pleiotropy (Fig. 2e,f and Additional file 1: Table S15).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel e",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Despite these profiles, all blood traits were linked to cancer risk to some extent (Fig. 2g).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel g",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel g",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel g",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "For instance, a significant enrichment of shared variants was found between reticulocytes and triple-negative breast cancer (TNBC) (Fig. 2h).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel h",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel h",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel h",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Next, analysis of the proportion of pleiotropic variants linked to genes associated with leukocyte telomere length revealed an enrichment in breast cancer caused by pathological variants of BRCA1 and TNBC (32% of variants), followed by luminal A breast cancer (LumA; 16%) and melanoma (12%; Fig. 3a).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Next, analysis of the proportion of pleiotropic variants linked to genes associated with leukocyte telomere length revealed an enrichment in breast cancer caused by pathological variants of BRCA1 and TNBC (32% of variants), followed by luminal A breast cancer (LumA; 16%) and melanoma (12%; Fig. 3a).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Hotspots of blood trait–cancer pleiotropism are present in the TERT and HLA regions\nExamining the location of pleiotropic variants throughout the genome indicated regions with a relatively high frequency of associations (Fig. 3b).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Analysis of the representation of pleiotropic associations relative to all examined variants in genomic bins of 1, 3 and 5 megabases (Mb) identified 81–159 regions with a significant pleiotropy enrichment (chi-squared test FDR-adjusted p < 0.05; Fig. 3c and Additional file 1: Table S18).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The genomic bins comprising associations with > 10 cancer types corresponded to the chromosomes 3p21, 5p15, 6p21-p22, 9p21, and 17q21, which, among other genes, encompass CC-motif chemokine receptors, TERT, human leukocyte antigens, interferons, and corticotropin-releasing hormone receptor 1, respectively (Fig. 3d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel d",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel d",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel d",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Thus, pleiotropic variants in 21 genes of chromosome 6p21-p22 were frequently found to be eQTLs in blood cells and/or lymphocytes (FDR < 0.05; Fig. 3d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel d",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Examining the location of pleiotropic variants throughout the genome indicated regions with a relatively high frequency of associations (Fig. 3b).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Analysis of the representation of pleiotropic associations relative to all examined variants in genomic bins of 1, 3 and 5 megabases (Mb) identified 81–159 regions with a significant pleiotropy enrichment (chi-squared test FDR-adjusted p < 0.05; Fig. 3c and Additional file 1: Table S18).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The genomic bins comprising associations with > 10 cancer types corresponded to the chromosomes 3p21, 5p15, 6p21-p22, 9p21, and 17q21, which, among other genes, encompass CC-motif chemokine receptors, TERT, human leukocyte antigens, interferons, and corticotropin-releasing hormone receptor 1, respectively (Fig. 3d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel d",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel d",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel d",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Thus, pleiotropic variants in 21 genes of chromosome 6p21-p22 were frequently found to be eQTLs in blood cells and/or lymphocytes (FDR < 0.05; Fig. 3d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel d",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "In six of the 12 (50%) immune cell types analyzed, the proportion of pleiotropic variants mapped to defined enhancers was significantly higher than expected, with the highest pleiotropic enrichment for enhancers in monocytes (FDR-adjusted p < 0.05; Fig. 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Several transcription factors were found to be overrepresented in the pleiotropic set, including some of those involved in hematopoiesis (EGR1, GATA1, and IRF1; Fig. 4b and Additional file 1: Table S19).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The regulatory features with the greatest overrepresentation in the pleiotropic variants were the binding of RNA polymerase II (POL2) and the tri-methylation of the fourth lysine residue of histone H3 (H3K4me3), which marks transcription start sites of active genes (Fig. 4b and Additional file 1: Table S19).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "This analysis revealed a significant overlap of the pleiotropic gene set with seven modules (FDR-adjusted phypergeometric values < 0.05; Fig. 4c and Additional file 1: Table S21), including a module regulated by the canonical myeloid lineage factor SPI1, also known as PU.1 [85].",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The signature of the pleiotropic gene set was found to be underexpressed in several progenitor cell states (Fig. 4d).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Comparison of the pleiotropic signature against 100 equivalent randomly chosen gene sets (random genes among those expressing TPM > 1 in all major immune cell types [48]) confirmed significant underexpression in progenitor cell populations (Fig. 4e).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel e",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel e",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel e",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The pleiotropic gene set appeared to be particularly strongly underexpressed in myeloid progenitor cell populations, including granulocyte–monocyte progenitors (GMPs), erythro-myeloid progenitors (EMP), and multipotent progenitors (MPPs) (Fig. 4e).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel e",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel e",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel e",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Following on from the indication that perturbed hematopoiesis is linked to blood trait–cancer pleiotropism, the pleiotropic gene set was found to have an overrepresentation of mouse orthologs that cause immune system alterations when mutated or altered by allelic variants [89] (Mammalian Phenotype ontology code MP:0005387; Fig. 4f).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "A detailed analysis of the five ontology terms corresponding to myeloid cell alterations revealed three of them to be significantly overrepresented in the pleiotropic gene set: “decreased myeloid cell number”, “abnormal myeloid cell number,” and “abnormal myeloid cell morphology” (Fig. 4g).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel g",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel g",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel g",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In six of the 12 (50%) immune cell types analyzed, the proportion of pleiotropic variants mapped to defined enhancers was significantly higher than expected, with the highest pleiotropic enrichment for enhancers in monocytes (FDR-adjusted p < 0.05; Fig. 4a).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Several transcription factors were found to be overrepresented in the pleiotropic set, including some of those involved in hematopoiesis (EGR1, GATA1, and IRF1; Fig. 4b and Additional file 1: Table S19).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The regulatory features with the greatest overrepresentation in the pleiotropic variants were the binding of RNA polymerase II (POL2) and the tri-methylation of the fourth lysine residue of histone H3 (H3K4me3), which marks transcription start sites of active genes (Fig. 4b and Additional file 1: Table S19).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "This analysis revealed a significant overlap of the pleiotropic gene set with seven modules (FDR-adjusted phypergeometric values < 0.05; Fig. 4c and Additional file 1: Table S21), including a module regulated by the canonical myeloid lineage factor SPI1, also known as PU.1 [85].",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The signature of the pleiotropic gene set was found to be underexpressed in several progenitor cell states (Fig. 4d).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Comparison of the pleiotropic signature against 100 equivalent randomly chosen gene sets (random genes among those expressing TPM > 1 in all major immune cell types [48]) confirmed significant underexpression in progenitor cell populations (Fig. 4e).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel e",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel e",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel e",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The pleiotropic gene set appeared to be particularly strongly underexpressed in myeloid progenitor cell populations, including granulocyte–monocyte progenitors (GMPs), erythro-myeloid progenitors (EMP), and multipotent progenitors (MPPs) (Fig. 4e).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel e",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel e",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel e",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Following on from the indication that perturbed hematopoiesis is linked to blood trait–cancer pleiotropism, the pleiotropic gene set was found to have an overrepresentation of mouse orthologs that cause immune system alterations when mutated or altered by allelic variants [89] (Mammalian Phenotype ontology code MP:0005387; Fig. 4f).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel f",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "A detailed analysis of the five ontology terms corresponding to myeloid cell alterations revealed three of them to be significantly overrepresented in the pleiotropic gene set: “decreased myeloid cell number”, “abnormal myeloid cell number,” and “abnormal myeloid cell morphology” (Fig. 4g).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel g",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel g",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel g",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Detailed examination of the pleiotropic loci identified numerous RNY genes, pseudogenes, and derived sequences (total n = 118) mapped in a region ± 50 kb from the pleiotropic variants across the cancer studies, with the exception of three settings: breast cancer caused by pathological variants in BRCA2, and gastroesophageal and kidney cancers (Fig. 5a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "There was no difference in the genomic distribution of the RNY-containing pleotropic loci relative to all human RNY-derived sequences (Kolmogorov–Smirnov test p > 0.05; Fig. 5b).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Then, the percentage of pleiotropic variants linked to RNY sequences was significantly higher than the expectation based on 1000 sets of 4093 randomly chosen variants—European MAF > 0.01 and r2 < 0.8 in any pair— and considering 767 RNY sequences annotated in the human genome, from chromosome 1 to 22, for which an average 2.8% of random variants mapped to RNY loci (pempirical < 0.001; Fig. 5c).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Indeed, among the established families of small noncoding RNAs, RNY sequences showed the closest concordance with pleiotropic loci (Fig. 5d).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel d",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel d",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel d",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Notably, this percentage was significantly higher than expected from a consideration of 1000 sets of 3847 randomly chosen variants (dbSNP build 154; pempirical < 0.001; Fig. 5e).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel e",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Detailed examination of the pleiotropic loci identified numerous RNY genes, pseudogenes, and derived sequences (total n = 118) mapped in a region ± 50 kb from the pleiotropic variants across the cancer studies, with the exception of three settings: breast cancer caused by pathological variants in BRCA2, and gastroesophageal and kidney cancers (Fig. 5a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "There was no difference in the genomic distribution of the RNY-containing pleotropic loci relative to all human RNY-derived sequences (Kolmogorov–Smirnov test p > 0.05; Fig. 5b).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Then, the percentage of pleiotropic variants linked to RNY sequences was significantly higher than the expectation based on 1000 sets of 4093 randomly chosen variants—European MAF > 0.01 and r2 < 0.8 in any pair— and considering 767 RNY sequences annotated in the human genome, from chromosome 1 to 22, for which an average 2.8% of random variants mapped to RNY loci (pempirical < 0.001; Fig. 5c).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Indeed, among the established families of small noncoding RNAs, RNY sequences showed the closest concordance with pleiotropic loci (Fig. 5d).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel d",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel d",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel d",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Notably, this percentage was significantly higher than expected from a consideration of 1000 sets of 3847 randomly chosen variants (dbSNP build 154; pempirical < 0.001; Fig. 5e).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel e",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Consistent with marks of active transcription and enhancers, the average expression value of the pleiotropic RNYs in normal tissue was found to be higher than that of non-pleiotropic RNYs, established from the data from 15 studies included in TCGA [95] (tissue samples n = 593; Wilcoxon rank-sum p = 0.014; Fig. 6b).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel b",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "This difference in expression was detected despite the positive correlation between the pleiotropic and non-pleiotropic RNY transcript sets (hereafter “signatures”): Pearson’s correlation coefficient (PCC) = 0.82, p < 2 × 10−16 (Fig. 6c).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel c",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel c",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel c",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Then, analysis of the RNY signatures in blood cell populations of neutrophils, monocytes, B, CD4 T, CD8 T, and natural killer cells [96] corroborated the overexpression of the pleiotropic set, and further indicated higher levels of this signature in myeloid relative to lymphoid cell types (2-tailed t-test p = 0.0003; Fig. 6d).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel d",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Similarly, we found that the expression profiles of the pleiotropic and non-pleiotropic RNY signatures were positively correlated with RO60 expression in TCGA normal tissue: PCC = 0.17 and 0.27; p = 3 × 10−5 and 2 × 10−11, respectively (Fig. 7a).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Seventeen and eight pleiotropic variants in RNY TSSs ± 50 kb were found to be linked to SLE risk variants when using two thresholds (European r2 > 0.4 and > 0.8, respectively), and these figures of correlated genetic elements were found to be greater than expected from 1000 sets of 917 randomly selected variants (European MAF > 0.01; Fig. 7b and Additional file 1: Table S25).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel b",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Similarly, we found that the expression profiles of the pleiotropic and non-pleiotropic RNY signatures were positively correlated with RO60 expression in TCGA normal tissue: PCC = 0.17 and 0.27; p = 3 × 10−5 and 2 × 10−11, respectively (Fig. 7a).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Seventeen and eight pleiotropic variants in RNY TSSs ± 50 kb were found to be linked to SLE risk variants when using two thresholds (European r2 > 0.4 and > 0.8, respectively), and these figures of correlated genetic elements were found to be greater than expected from 1000 sets of 917 randomly selected variants (European MAF > 0.01; Fig. 7b and Additional file 1: Table S25).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel b",
        "figure_key": "figure_7"
      }
    ]
  }
]